Although definitions of gain-of-function differ, investigative reports leave no question researchers manipulated ...

CAR-T cell therapy achieves 18-year survival milestone in cancer patient Innovative cancer treatment shows promise as ...

The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ... Influenza A Viruses Adapt Shape in Response to Environmental Pressures Feb. 10, 2025 — Influenza A virus ...

Uncertainty over U.S. foreign aid’s future, as Trump ally Elon Musk dismantles USAID, has thrown the global campaign to ...

The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...

NB: This forum also includes a pre-conference to Minding Animals (Newcastle, Australia, 2009). See the Pre-Conference page ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

On the eve of Donald Trump's inauguration, the US Department of Health banned the financing and activities of the EcoHealth ...

CRISPR also didn’t seem to impact off-target sites. Virotherapy is the use of viruses to selectively kill cancer cells. The viruses used in virotherapy are called oncolytic viruses. An oncolytic ...

This manuscript describes an important finding of the transcriptional control of a chimeric gene transfer agents (GTA) cluster in Bartonella by a processive anti-termination factor (BrrG). The ...